MedPath

Study to Evaluate the Effect of Qingre Shuji Decoction combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with ankylosing spondylitis&#32

Phase 1
Not yet recruiting
Conditions
ankylosing spondylitis
Registration Number
ITMCTR2200006555
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

?18–75 years old ;
?Patients met the diagnostic criteria of Western medicine and disease activity, and the VAS score of spinal pain (the second item of BASDAI) was = 40 mm.
?Patients who met the diagnostic criteria of kidney deficiency and dampness-heat syndrome in TCM ;
?voluntary signing of informed consent ;
?Drug cleaning : SASP, methotrexate (MTX), leflunomide (LEF) and other antirheumatic drugs, hormones, biological agents or small molecule targeted drugs were not used more than 1 month before randomization.

Exclusion Criteria

?pregnant or lactating women and mental patients with severe malnutrition or severe damage to the heart, brain, kidney and hematopoietic system ;
?patients with other rheumatic diseases ;
?Patients with severe spinal and hip joint dysfunction who needed surgery during this study ;
?Concurrent NSAIDs use contraindications ;
?contraindications for combined use of biological agents.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effective rate of ASAS20 at week 16;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath